サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1702026

局所麻酔薬市場：薬剤タイプ別、投与方法別、流通チャネル別、地域別、2025-2033年

Local Anesthesia Drugs Market Report by Drug Type, Mode of Administration, Distribution Channel, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 144 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.69円
局所麻酔薬市場：薬剤タイプ別、投与方法別、流通チャネル別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

局所麻酔薬市場の世界市場規模は2024年に31億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに43億米ドルに達し、2025-2033年の成長率（CAGR）は3.52％になると予測しています。外科手術の増加、慢性疾患の影響を受けやすい老年人口の増加、政府医療支出の増加、頻繁な医療介入を必要とする慢性疾患の有病率の上昇が、市場成長を促す主な要因です。

局所麻酔薬は、神経終末の興奮を抑制したり末梢神経の伝導を遮断したりすることで麻酔を作り出す化合物です。局所麻酔薬は一般に、局所用クリームとして入手可能で、小手術、生検、歯科治療、陣痛・分娩、産科処置の際には注射やスプレーで投与されます。口内炎やのどの痛みなど、痛みを伴う症状の治療に役立ち、切り傷、軽いやけど、日焼け、ひっかき傷、虫さされ、ツタウルシなどによるかゆみを和らげます。また、胃炎、食道炎、食道裂孔ヘルニア、消化性潰瘍の胸やけなどの際に、迅速かつ効果的に痛みを和らげます。

局所麻酔薬市場傾向：

人工内耳埋め込み術、腹腔鏡下大腸切除術、腹腔鏡下子宮摘出術、二次的股関節置換術、人工膝関節置換術など、複数の手技を必要とする心血管疾患、呼吸器疾患、その他の慢性疾患の有病率の上昇は、市場の成長を後押しする重要な要因の1つです。さらに、術後の疼痛緩和を必要とする外科的介入を受ける高齢者人口の増加が、世界中で局所麻酔薬の需要を喚起しています。さらに、アルチカイン、レボブピバカイン、ロピバカインのような新規で効果的な医薬品の導入と相まって、歯科手術の件数が増加していることも、市場成長を後押ししています。これとは別に、個人の外見に対する意識の高まりから、ボツリヌス毒素や顔面フィラー注射などの低侵襲（MI）美容外科手術の需要が増加しており、これが市場成長に寄与しています。これに加えて、医療ツーリズム活動の拡大と医療インフラの開拓が、市場の明るい見通しを生み出しています。このほか、コンピュータを利用した局所麻酔薬投与や振動触覚装置などの技術的進歩も、市場にプラスの推進力を与えると予想されます。

本レポートで扱う主な質問

  • 2024年の世界の局所麻酔薬市場の市場規模は？
  • 2025-2033年における局所麻酔薬市場の世界市場成長率は？
  • 世界の局所麻酔薬市場を牽引する主要因は何か？
  • 世界の局所麻酔薬市場に対するCOVID-19の影響は？
  • 世界の局所麻酔薬市場の薬剤タイプ別の内訳は？
  • 世界の局所麻酔薬市場の投与形態別の内訳は？
  • 世界の局所麻酔薬市場の流通チャネル別の内訳は？
  • 世界の局所麻酔薬市場における主要地域は？
  • 世界の局所麻酔薬市場の主要プレーヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の局所麻酔薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：薬剤タイプ別

  • リドカイン
  • ブピバカイン
  • ベンゾカイン
  • ロピバカイン
  • プリロカイン
  • クロロプロカイン
  • その他

第7章 市場内訳：投与方法別

  • 注射
  • 表面麻酔

第8章 市場内訳：流通チャネル別

  • 病院薬局
  • 薬局
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Aspen Pharmacare Holdings Limited
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Endo International plc
    • Fresenius SE & Co. KGaA
    • Hikma Pharmaceuticals plc
    • Pacira Biosciences Inc.
    • Pfizer Inc.
    • Pierrel S.p.A.
    • Septodont
図表

List of Figures

  • Figure 1: Global: Local Anesthesia Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Local Anesthesia Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Local Anesthesia Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Local Anesthesia Drugs Market: Breakup by Drug Type (in %), 2024
  • Figure 5: Global: Local Anesthesia Drugs Market: Breakup by Mode of Administration (in %), 2024
  • Figure 6: Global: Local Anesthesia Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Local Anesthesia Drugs Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Local Anesthesia Drugs (Lidocaine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Local Anesthesia Drugs (Lidocaine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Local Anesthesia Drugs (Bupivacaine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Local Anesthesia Drugs (Bupivacaine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Local Anesthesia Drugs (Benzocaine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Local Anesthesia Drugs (Benzocaine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Local Anesthesia Drugs (Ropivacaine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Local Anesthesia Drugs (Ropivacaine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Local Anesthesia Drugs (Prilocaine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Local Anesthesia Drugs (Prilocaine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Local Anesthesia Drugs (Chloroprocaine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Local Anesthesia Drugs (Chloroprocaine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Local Anesthesia Drugs (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Local Anesthesia Drugs (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Local Anesthesia Drugs (Injectables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Local Anesthesia Drugs (Injectables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Local Anesthesia Drugs (Surface Anesthetic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Local Anesthesia Drugs (Surface Anesthetic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Local Anesthesia Drugs (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Local Anesthesia Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Local Anesthesia Drugs (Pharmacy Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Local Anesthesia Drugs (Pharmacy Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Local Anesthesia Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Local Anesthesia Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Local Anesthesia Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Local Anesthesia Drugs Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Local Anesthesia Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Local Anesthesia Drugs Industry: SWOT Analysis
  • Figure 82: Global: Local Anesthesia Drugs Industry: Value Chain Analysis
  • Figure 83: Global: Local Anesthesia Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Local Anesthesia Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Local Anesthesia Drugs Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 3: Global: Local Anesthesia Drugs Market Forecast: Breakup by Mode of Administration (in Million USD), 2025-2033
  • Table 4: Global: Local Anesthesia Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Local Anesthesia Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Local Anesthesia Drugs Market: Competitive Structure
  • Table 7: Global: Local Anesthesia Drugs Market: Key Players
目次
Product Code: SR112025A5991

The global local anesthesia drugs market size reached USD 3.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.3 Billion by 2033, exhibiting a growth rate (CAGR) of 3.52% during 2025-2033. The increasing surgical procedures, growing geriatric population susceptible to chronic ailments, rising government healthcare spending, and rising prevalence of chronic diseases requiring frequent medical interventions are the major factors impelling the market growth.

Local anesthesia drugs are chemical compounds producing anesthesia by inhibiting the excitation of nerve endings or blocking conduction in peripheral nerves. They are generally available as topical creams or administered via injections or sprays during minor surgeries, biopsies, dental care, labor and delivery, and obstetrical procedures. They help treat painful conditions, such as mouth ulcers and sore throat, and relieve itching caused by cuts, minor burns, sunburns, scratches, insect bites, and poison ivy. They also assist in rapid and effective pain relief during gastritis, esophagitis, hiatus hernia, and heartburn of peptic ulcer.

Local Anesthesia Drugs Market Trends:

The rising prevalence of cardiovascular, respiratory, and other chronic diseases that need several procedures, such as cochlear implantation, laparoscopic colectomy, laparoscopic hysterectomy, secondary hip replacement, and knee replacement, represents one of the key factors bolstering the market growth. Furthermore, the growing geriatric population undergoing surgical interventions that require post-operative pain relief is catalyzing the demand for local anesthesia drugs across the globe. Moreover, the increasing number of dental surgeries, in confluence with the introduction of novel and effective medicines like articaine, levobupivacaine and ropivacaine, is propelling the market growth. Apart from this, due to the increasing consciousness about physical appearance among individuals, there is a rise in the demand for minimally invasive (MI) cosmetic surgical procedures, such as botulinum toxin and facial filler injections, which is contributing to the market growth. In addition to this, expanding medical tourism activities, along with developments in the healthcare infrastructure, are creating a positive market outlook. Besides this, technological advancements, including computer-based local anesthetic delivery and vibrotactile devices, are anticipated to provide a positive thrust to the market.

Key Market Segmentation:

Breakup by Drug Type:

  • Lidocaine
  • Bupivacaine
  • Benzocaine
  • Ropivacaine
  • Prilocaine
  • Chloroprocaine
  • Others

Breakup by Mode of Administration:

  • Injectables
  • Surface Anesthetic

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Pharmacy Stores
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aspen Pharmacare Holdings Limited, B. Braun Melsungen AG, Baxter International Inc., Endo International plc, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals plc, Pacira Biosciences Inc., Pfizer Inc., Pierrel S.p.A. and Septodont.

Key Questions Answered in This Report

  • 1.What was the size of the global local anesthesia drugs market in 2024?
  • 2.What is the expected growth rate of the global local anesthesia drugs market during 2025-2033?
  • 3.What are the key factors driving the global local anesthesia drugs market?
  • 4.What has been the impact of COVID-19 on the global local anesthesia drugs market?
  • 5.What is the breakup of the global local anesthesia drugs market based on the drug type?
  • 6.What is the breakup of the global local anesthesia drugs market based on the mode of administration?
  • 7.What is the breakup of the global local anesthesia drugs market based on the distribution channel?
  • 8.What are the key regions in the global local anesthesia drugs market?
  • 9.Who are the key players/companies in the global local anesthesia drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Local Anesthesia Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Lidocaine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bupivacaine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Benzocaine
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Ropivacaine
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Prilocaine
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Chloroprocaine
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Mode of Administration

  • 7.1 Injectables
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Surface Anesthetic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacy Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aspen Pharmacare Holdings Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Drug Type Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Drug Type Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Drug Type Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Endo International plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Drug Type Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fresenius SE & Co. KGaA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Drug Type Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hikma Pharmaceuticals plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Drug Type Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Pacira Biosciences Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Drug Type Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Drug Type Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pierrel S.p.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Drug Type Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Septodont
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Drug Type Portfolio